tility of testing Gluten immunogenic peptide levels in urine for checking compliance to diet in children with celiac disease.
Not Applicable
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive system
- Registration Number
- CTRI/2024/08/072256
- Lead Sponsor
- Dr Shreya Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children newly diagnosed with Celiac disease between 1-12 years age, presenting to the Department of Pediatrics. Diagnosis of CD will be made as per ESPGHAN 2020 criteria.
Exclusion Criteria
1.Patients with known chronic inflammatory bowel disease 2.Patients with a history of necrotizing enterocolitis and known short bowel syndrome 3.Patients with known chronic kidney disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the urinary GIP levels from baseline after institution of gluten free dietTimepoint: At 1 week and at 1 month of starting gluten free diet
- Secondary Outcome Measures
Name Time Method Association between Urinary GIP levels and anti tTG-IgA levels after 1 month of gluten free dietTimepoint: At 1 month of gluten free diet